全文获取类型
收费全文 | 48090篇 |
免费 | 3728篇 |
国内免费 | 1162篇 |
专业分类
耳鼻咽喉 | 625篇 |
儿科学 | 2022篇 |
妇产科学 | 1193篇 |
基础医学 | 4098篇 |
口腔科学 | 604篇 |
临床医学 | 5244篇 |
内科学 | 7484篇 |
皮肤病学 | 520篇 |
神经病学 | 2916篇 |
特种医学 | 2244篇 |
外国民族医学 | 3篇 |
外科学 | 5455篇 |
综合类 | 5080篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 5780篇 |
眼科学 | 1109篇 |
药学 | 4374篇 |
25篇 | |
中国医学 | 1603篇 |
肿瘤学 | 2596篇 |
出版年
2024年 | 92篇 |
2023年 | 881篇 |
2022年 | 1433篇 |
2021年 | 2553篇 |
2020年 | 2096篇 |
2019年 | 2160篇 |
2018年 | 1971篇 |
2017年 | 1775篇 |
2016年 | 1693篇 |
2015年 | 1611篇 |
2014年 | 3327篇 |
2013年 | 3562篇 |
2012年 | 2606篇 |
2011年 | 3081篇 |
2010年 | 2447篇 |
2009年 | 2409篇 |
2008年 | 2461篇 |
2007年 | 2344篇 |
2006年 | 1869篇 |
2005年 | 1696篇 |
2004年 | 1379篇 |
2003年 | 1198篇 |
2002年 | 993篇 |
2001年 | 826篇 |
2000年 | 660篇 |
1999年 | 620篇 |
1998年 | 558篇 |
1997年 | 504篇 |
1996年 | 440篇 |
1995年 | 366篇 |
1994年 | 340篇 |
1993年 | 300篇 |
1992年 | 265篇 |
1991年 | 252篇 |
1990年 | 214篇 |
1989年 | 204篇 |
1988年 | 163篇 |
1987年 | 169篇 |
1986年 | 161篇 |
1985年 | 213篇 |
1984年 | 207篇 |
1983年 | 144篇 |
1982年 | 162篇 |
1981年 | 115篇 |
1980年 | 95篇 |
1979年 | 97篇 |
1978年 | 66篇 |
1977年 | 58篇 |
1976年 | 38篇 |
1973年 | 26篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2020,32(5):303-315
The lung is the preferred site of metastasis from soft tissue sarcoma (STS). This systematic review aims to evaluate the outcomes of stereotactic body radiotherapy (SBRT) and metastasectomy (MTS) for the treatment of lung metastases from STS. A systematic review was carried out according to the PRISMA protocol. PubMed, Medline, EMBASE, Cochrane Library, Ovid and Web of Knowledge databases were searched for English-language articles to December 2018 using a predefined strategy. Retrieved studies were independently screened and rated for relevance. Data were extracted by two researchers. In total, there were 1306 patients with STS: 1104 underwent MTS and 202 had SBRT. The mean age ranged from 40 to 55.8 years in the MTS group and from 47.9 to 64 years in the SBRT group. The cumulative death rate was 72% (95% confidence interval 59–85%) in the MTS group and 56% (38–74%) in the SBRT group. The cumulative mean overall survival time was 46.7 months (36.4–57.0%) in the MTS group and 47.6 months (33.7–61.5%) in the SBRT group. The cumulative rate of patients alive with disease was 5% (2–9%) in the MTS group and 15% (6–36%) in the SBRT group. Finally, the cumulative rate of patients alive without disease in the two groups was 19% (9–29%) and 20% (10–50%), respectively. Our study showed that local treatment of pulmonary metastases from STS with SBRT, compared with surgery, was associated with a lower cumulative overall death rate and similar overall survival time and survival rates without disease. By contrast, SBRT was associated with a higher survival rate with disease than MTS. Large randomised trials are necessary to confirm these findings and to establish whether SBRT may be a reliable option for early stage disease. 相似文献
42.
43.
《Surgery (Oxford)》2021,39(9):591-597
Infections of the ear, nose and throat are common. The majority of these infections are managed by the primary care physicians and they settle with conservative and medical management. However, a small group can progress to become troublesome and develop complications to the extent that they may require surgical intervention. Some of the infections can lead to life-threatening complications, therefore awareness and correct diagnosis along with appropriate management is paramount. Foreign bodies in the ear, nose and throat are commonly encountered. The location and type of foreign body can have an implication on the urgency of action and the possible complications. In this article the common ENT infections and foreign bodies and their management are discussed. 相似文献
44.
45.
46.
47.
48.
49.
《Yao wu shi pin fen xi = Journal of food and drug analysis.》2019,27(2):585-594
Di-(2-propylheptyl) phthalate (DPHP) is a plasticizer and has been suggested to be a subchronic toxicant in rats. DPHP has been approved to be used in food containers and handling by the U.S. Food and Drug Administration. The use of DPHP is still increasing, and the risk of human exposure to DPHP via food may be high. Exposure markers measured in human samples are commonly used to monitor human exposure levels. Ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) and a rat model were used to discover tentative DPHP exposure markers. DPHP and mono-(2-propylheptyl) phthalate (MPHP) were used as the precursors for calculating metabolite candidates using biotransformation mass changes of known enzymatic reactions. A rat model was designed to validate these metabolite candidates as tentative exposure markers. A total of 28 signals show dose–response relationships and these signals contain a few isomers. The chemical structures of 15 tentative exposure marker signals were speculated based on the product ion mass spectra from MS/MS analysis. These 15 signals included 7 chemical structures and some of them may be isomers. The different arrangement of the atoms in space of these isomers should be validated by standard compounds in the future studies. Among the 7 speculated chemical structures, 2 structures were novel tentative DPHP metabolites, and 5 structures have been previously reported in the literature. The results indicate that using UPLC-MS and a rat model can be used to identify tentative toxicant exposure markers. 相似文献
50.
《Drug metabolism and pharmacokinetics》2019,34(1):87-94
The purpose of this study was to elucidate the involvement of Mate1 in the tubular secretion of trimethoprim and saturation of Mate1-mediated efflux to address the mechanisms underlying the pharmacokinetic drug interactions with trimethoprim. Trimethoprim is a more potent inhibitor of MATE2-K than MATE1 with Ki values (μM) of 0.030–0.28 and 2.4–5.9, respectively. Trimethoprim is a substrate of human MATE1 and MATE2-K with Km values of 2.3 ± 0.9 and 0.018 ± 0.004 μM, and mouse Mate1, but not human OCT2, mouse Oct1 and Oct2. Pyrimethamine significantly reduced the renal clearance (CLR) of trimethoprim (mL/min/kg) from 40.0 ± 5.1 to 20.1 ± 3.7 (p < 0.05). Trimethoprim was given to mice at three infusion rates (150, 500, and 1500 nmol/min/kg). Together with an increase in the plasma concentrations of trimethoprim, the CLR (mL/min/kg) of trimethoprim decreased to 25.9 ± 3.2, 13.5 ± 5.7, and 8.92 ± 1.50 at the respective rates. Trimethoprim decreased the CLR of rhodamine 123 in an infusion rate-dependent manner: 11.5 ± 1.3 (control), 5.17 ± 1.55, 1.31 ± 0.50, and 0.532 ± 0.180. These results suggest that Mate1 mediates the tubular secretion of trimethoprim, and at therapeutic doses, MATEs-mediated efflux can be saturated, and thereby, cause drug interactions with other MATE substrates. 相似文献